Shaw Ibrahim, Aryee Aaron Albert, Ali Yimer Seid, Boafo George Frimpong, Tian Jingjing, Mlambo Ronald, Tan Songwen, Chen Chuanpin
Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, China.
College of Chemistry, Zhengzhou University, Zhengzhou 450001, China.
Chin J Nat Med. 2025 Jun;23(6):700-713. doi: 10.1016/S1875-5364(25)60889-2.
Natural herbs demonstrate significant therapeutic potential in managing chronic and complex diseases; however, their clinical application faces limitations due to low bioavailability, instability, toxicity, and herb-drug interactions. Furthermore, insufficient standardized evidence and global acceptance impede their widespread adoption. Liposomes, nanocarriers consisting of a phospholipid bilayer enclosing an aqueous core, present a promising approach for enhancing the pharmacokinetics and therapeutic efficacy of herbal compounds. These adaptable systems can encapsulate both hydrophilic and hydrophobic agents, enabling targeted drug delivery and enhanced stability. Moreover, liposomes can be modified to carry diagnostic and imaging agents, enabling precise disease detection and monitoring. While liposomes offer potential as an innovative delivery technology for herbal remedies, their application in Traditional Chinese Medicine (TCM) remains relatively unexplored. TCM, with its holistic, energy-based approach to health and organ function, presents distinct challenges regarding formulation and delivery. This review examines the therapeutic potential of herbal medicines, emphasizing how liposomes address delivery challenges within the TCM framework. It also investigates the integration of TCM with Western medical practices, demonstrating how liposomal systems may bridge these approaches. The review analyzes key formulation techniques for TCM-loaded liposomes, particularly the microfluidic method, which demonstrates superior control over particle size and encapsulation efficiency compared to conventional methods. The analysis addresses barriers to integrating liposomal delivery systems with TCM, including physicochemical properties, scalability issues, and regulatory challenges. Finally, this review provides strategic recommendations for overcoming these obstacles and identifies future research directions to maximize the potential of liposomal technology in enhancing TCM therapies.
天然草药在治疗慢性和复杂疾病方面显示出显著的治疗潜力;然而,由于生物利用度低、稳定性差、毒性以及草药与药物相互作用,其临床应用面临限制。此外,标准化证据不足和全球认可度不高阻碍了它们的广泛应用。脂质体是由磷脂双分子层包裹水相核心组成的纳米载体,是增强草药化合物药代动力学和治疗效果的一种有前景的方法。这些适应性系统可以封装亲水性和疏水性药物,实现靶向给药并提高稳定性。此外,脂质体可以进行修饰以携带诊断和成像剂,实现疾病的精确检测和监测。虽然脂质体作为草药创新给药技术具有潜力,但其在传统中医(TCM)中的应用仍相对未被探索。传统中医以整体、基于能量的方法看待健康和器官功能,在制剂和给药方面提出了独特的挑战。本综述探讨了草药的治疗潜力,强调脂质体如何在传统中医框架内解决给药挑战。它还研究了传统中医与西医实践的整合,展示了脂质体系统如何架起这些方法之间的桥梁。综述分析了载有中药的脂质体的关键制剂技术,特别是微流控方法,与传统方法相比,该方法在粒径控制和包封效率方面表现出卓越的性能。分析还涉及脂质体给药系统与传统中医整合的障碍,包括物理化学性质、可扩展性问题和监管挑战。最后,本综述提供了克服这些障碍的战略建议,并确定了未来的研究方向,以最大限度地发挥脂质体技术在增强中医治疗方面的潜力。